(Q77709638)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9860477%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

title

Moderate activation of the apoptosis inhibitor bcl-xL worsens the prognosis in pancreatic cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9860477%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

1 reference

1 reference

1

H Friess

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9860477%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

8

M W Büchler

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9860477%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

3

A Andrén-Sandberg

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9860477%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

author name string

Z Lu

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9860477%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

P Berberat

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9860477%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

A Zimmermann

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9860477%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

G Adler

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9860477%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

R Schmid

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9860477%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

language of work or name

English

0 references

publication date

1 December 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9860477%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9860477%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

volume

228

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9860477%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9860477%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

page(s)

780-787

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9860477%20AND%20SRC:MED&resulttype=core&format=json

Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl-2/immunoglobulin transcript resulting from the t(14;18) translocation

7 December 2019

cites work

1 reference

12 December 2020

Presence of two signaling TGF-beta receptors in human pancreatic cancer correlates with advanced tumor stage

1 reference

12 December 2020

bcl-2 and other genomic alterations in the prognosis of large-cell lymphoma

1 reference

12 December 2020

bcl-2-immunoglobulin transgenic mice demonstrate extended B cell survival and follicular lymphoproliferation

1 reference

12 December 2020

Cytogenetic analysis of 434 consecutively ascertained specimens of non-Hodgkin's lymphoma: clinical correlations

1 reference

12 December 2020

A randomized controlled trial of adjuvant immunotherapy (murine monoclonal antibody 494/32) in resectable pancreatic cancer.

1 reference

12 December 2020

bcl-2 inhibits multiple forms of apoptosis but not negative selection in thymocytes

1 reference

12 December 2020

bcl-2 transgene inhibits T cell death and perturbs thymic self-censorship

1 reference

12 December 2020

Bcl-2 initiates a new category of oncogenes: regulators of cell death

1 reference

12 December 2020

Treatment of duct carcinoma of the pancreas with the LH-RH analogue buserelin

1 reference

12 December 2020

Bcl-2 oncoprotein blocks chemotherapy-induced apoptosis in a human leukemia cell line.

1 reference

12 December 2020

Enhanced expression of the type II transforming growth factor beta receptor in human pancreatic cancer cells without alteration of type III receptor expression.

1 reference

12 December 2020

bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death

1 reference

12 December 2020

Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death

1 reference

12 December 2020

Enhanced expression of transforming growth factor beta isoforms in pancreatic cancer correlates with decreased survival

1 reference

12 December 2020

Bcl-2 and the regulation of programmed cell death

1 reference

12 December 2020

Bcl-2/Bax: a rheostat that regulates an anti-oxidant pathway and cell death

1 reference

12 December 2020

[Surgical results and indications for adjuvant measures in pancreatic cancer]

1 reference

12 December 2020

Identification of immunosuppressant-induced apoptosis in a murine B-cell line and its prevention by bcl-x but not bcl-2.

1 reference

12 December 2020

Chemotherapy prolongs survival in inoperable pancreatic carcinoma.

1 reference

12 December 2020

Immunohistochemical analysis of in vivo patterns of Bcl-X expression

1 reference

12 December 2020

Bad, a heterodimeric partner for Bcl-XL and Bcl-2, displaces Bax and promotes cell death

1 reference

12 December 2020

Bcl-xL is expressed in neuroblastoma cells and modulates chemotherapy-induced apoptosis

1 reference

12 December 2020

Overexpression of Bcl-XL by cytotoxic drug exposure confers resistance to ionizing radiation-induced internucleosomal DNA fragmentation

1 reference

12 December 2020

Identification of K-ras mutations in pancreatic juice in the early diagnosis of pancreatic cancer

1 reference

12 December 2020

Expression and in-situ localization of genes coding for extracellular matrix proteins and extracellular matrix degrading proteases in pancreatic cancer.

1 reference

12 December 2020

Bcl-XL protects cancer cells from p53-mediated apoptosis

1 reference

12 December 2020

Bax-independent inhibition of apoptosis by Bcl-XL.

1 reference

12 December 2020

Role of bcl-X(L) in the control of apoptosis in murine myeloma cells

1 reference

12 December 2020

Elevated expression of Bcl-X and reduced Bak in primary colorectal adenocarcinomas.

1 reference

12 December 2020

Total pancreatectomy for cancer of the pancreas: is it appropriate?

1 reference

12 December 2020

Kaposi's sarcoma tumor cells preferentially express Bcl-xL.

1 reference

12 December 2020

BCL-2 family proteins: regulators of cell death involved in the pathogenesis of cancer and resistance to therapy

1 reference

12 December 2020

Pancreatic cancer: the potential clinical relevance of alterations in growth factors and their receptors

1 reference

12 December 2020

Suppression of apoptosis by Bcl-2 or Bcl-xL promotes susceptibility to mutagenesis.

1 reference

12 December 2020

KAI1 expression is up-regulated in early pancreatic cancer and decreased in the presence of metastases

1 reference

12 December 2020

Importance of the Bcl-2 family in cell death regulation

1 reference

12 December 2020

Over-expression of bcl-xL gene in human gastric adenomas and carcinomas.

1 reference

12 December 2020

Cancer statistics, 1997.

1 reference

12 December 2020

The cell death inhibitor Bcl-2 and its homologues influence control of cell cycle entry

1 reference

12 December 2020

Enhanced expression of urokinase plasminogen activator and its receptor in pancreatic carcinoma

1 reference

12 December 2020

Results of adjuvant therapy in resected pancreatic cancer

1 reference

12 December 2020

Increased expression of transforming growth factor beta s after acute oedematous pancreatitis in rats suggests a role in pancreatic repair

1 reference

12 December 2020

Enhanced urokinase plasminogen activation in chronic pancreatitis suggests a role in its pathogenesis

1 reference

12 December 2020

The anti-apoptosis function of Bcl-2 can be genetically separated from its inhibitory effect on cell cycle entry

1 reference

12 December 2020

Alternative promoters and exons, somatic mutation and deregulation of the Bcl-2-Ig fusion gene in lymphoma

1 reference

12 December 2020

10.1097/00000658-199812000-00009

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9860477%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

0 references

1 reference